List of medications used by doctors for the treatment of Coronavirus

Medications for covid19

Since SARS-CoV-2 is a virus, considerable scientific attention has been focused on repurposing approved antiviral drugs that were developed for prior outbreaks such as MERS, SARS, and West Nile virus.

Some coronavirus medications are enlisted, which could work against coronavirus. 

1. ANTIMALARIAL AGENTS:

Chloroquine and Hydroxychloroquine:
  • Chloroquine is an anti-malarial medication that is also used against some auto-immune diseases. On 18 March, the WHO announced that chloroquine and the related hydroxychloroquine sulphate would be among the four drugs studied as part of the Solidarity clinical trial. 
  • On March 28, 2020 the FDA authorized the use of hydroxychloroquine sulfate and chloroquine phosphate under an Emergency Use Authorization (EUA).
  • On April 9th, the National Institutes of Health began the first clinical trial to assess whether hydroxychloroquine 200 mg is safe and effective to treat COVID-19. 
2. ANTIVIRAL AGENTS:

Lopinavir/Ritonavir:
  • The combination of lopinavir and ritonavir tablets (Kaletra), is used by the doctors for the treatment of coronavirus. 
  • Combination of these antivirals drugs were designed to inhibit HIV from replicating by binding to the protease. A team of researchers at the University of Colorado are trying to modify the lopinavir and ritonavir to find a compound that will bind with the protease of SARS-CoV-2.
Oseltamivir:
  • This medication, sold under the brand name Tamiflu, is an antiviral medication mainly approved in order to use for treating and preventing influenza. 
  • Oseltamivir Phosphate (Tamiflu) in combination with some other drugs are currently being studied in clinical trials for the treatment of COVID-19. 
  • Some ongoing trials of Oseltamivir 75 mg are mentioned as follows:
  1. Various combinations of protease inhibitors, oseltamivir, favipiravir, and chloroquine in patients with mild to severe COVID-19. 
  2. ASC09F + oseltamivir vs Ritonavir + oseltamivir vs oseltamivir in patients with non-severe COVID-19.
  3. Abidol hydrochloride vs Oseltamivir vs Lopinavir/ritonavir in patients with mild to severe COVID-19. 
Favipiravir:
  • The clinical trials in China's Wuhan and Shenzhen, claimed to show that favipiravir was "clearly effective".
  • Of 35 patients in Shenzhen tested negative in a median of 4 days, while the length of illness was 11 days in the 45 patients who did not receive it.
  • On 22 March 2020, Italy approved the drug for experimental use against COVID-19 and began conducting trials in the three regions most affected by the disease.
3. BROAD-SPECTRUM AGENTS:

Ribavirin: In China, this medication was recommended for the treatment of COVID-19.
Umifenovir: This medication was also recommended for the treatment of COVID-19.

4. INTERFERONS:

Interferon-β:  This is previously tested against MERS in combination with other drugs.

5. DRUGS ORIGINALLY DEVELOPED FOR SARS:

APN01 (ACE2 protein decoy): APN01 is a form of angiotensin-converting enzyme 2, a Phase II trial is underway with 200 patients to be recruited from severe, hospitalized cases in Denmark, Germany, and Austria to determine the effectiveness of the treatment.

6. ANTIBIOTICS: 
Some antibiotics that have been identified as potentially repurposable as COVID-19 treatments:
  • Teicoplanin
  • Oritavancin
  • Dalbavancin
  • Monensin
  • Azithromycin
  • Antiparasitic
  • Ivermectin
7. ANTI-IL-6:

Tocilizumab (Anti-IL-6 receptor): Anti-IL-6 receptor was approved by China.Also trials in Italy and China.

Read:- RITONAVIR-LOPINAVIR COMBINATION IS REALLY HELPFUL IN COVID-19 TREATMENT

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found ...
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or...
Read more

Difference Between Multiple Myeloma And Leukemia

Image
What is multiple myeloma:  This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma. The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems. At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy. And the medication of multiple myeloma includes: Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphami...
Read more